Navigation Links
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Anthera Pharmaceuticals, Inc. (ANTH)
Date:1/17/2017

NEW YORK, Jan. 17, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Anthera Pharmaceuticals, Inc. ("Anthera" or the "Company") (NASDAQ: ANTH). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/anth.  

The investigation concerns whether Anthera and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

On November 10, 2016, Anthera released that "the CHABLIS-SC1 clinical trial with blisibimod for the treatment of systemic lupus erythematosus (SLE) failed to meet its primary endpoint based upon the SLE Responder Index-6 (SRI-6) at 52 weeks." Then on December 27, 2016, Anthera made public that its SOLUTION Phase 3 Study for liprotamase also failed to meet its primary endpoint and Anthera said it would conduct a new liprotamase study. During this time, Anthera stock dropped 73%, from a previous close on November 9, 2016 of $2.78 per share to a close of $0.74 per share on December 28, 2016. 

If you are aware of any facts relating to this investigation, or purchased Anthera shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/anth. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:  
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-anthera-pharmaceuticals-inc-anth-300391195.html


'/>"/>
SOURCE Bronstein, Gewirtz & Grossman, LLC
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. TNI BioTech, Inc. Corporations CEO Issues Letter to Shareholders Discussing Recent Events
2. Medifirst Solutions, Inc. Announces Update To Shareholders
3. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG
4. 3SBio Inc. Announces Shareholders Approval of the Amended Merger Agreement
5. SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in AMAG Pharmaceuticals, Inc. of Class Action Lawsuit Investigation - AMAG
6. Royalty Pharma Recommends Elan Shareholders vote "NO" on each of the Elan Resolutions at the Elan extraordinary general meeting
7. Cytos Invites to the Annual Shareholders Meeting 2013
8. CVBT Shareholders Vote for Change
9. Royalty Pharma Urges Elan Shareholders to Vote AGAINST ALL FOUR Elan Resolutions Today
10. Millenia Hope, Inc. Updates to Shareholders
11. Sinovac Schedules 2013 Annual Meeting of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2019)... ... July 17, 2019 , ... ... solution needed to attract new customers, better engage existing patients and collaborate with ... digital marketing services in tandem with an all-in-one platform. With the Updox approach, ...
(Date:7/17/2019)... ... 2019 , ... Triple W, an innovator of connected health ... will be highlighted at the Japan - U.S. Innovation Awards Symposium ... recognizes startups with Japanese founders developing exciting technologies and highly innovative business ideas ...
(Date:7/17/2019)... , ... July 17, 2019 , ... ... 11-13, in Phoenix, will provide strategies to keep pathologists, laboratory professionals and residents ... to improve outcomes and enhance patient care. , Renowned Speakers Covering Crucial ...
Breaking Medicine Technology:
(Date:7/17/2019)... HILLS, Calif. (PRWEB) , ... July 17, 2019 ... ... & toning device, the first that is capable of treating up to eight ... designed to perform total body muscle toning much faster and easier than previous muscle ...
(Date:7/17/2019)... ... July 17, 2019 , ... In order to achieve the mission, the design ... occur, from the accident scene, to the moment the teeth are replanted and fixed ... treatment. , They identified seven points, so called links in a chain, along this ...
(Date:7/17/2019)... ... July 17, 2019 , ... ... participating in Medicare Advantage, Medicaid, and Marketplace programs is pleased to announce the ... Electronic Health Records (EHR) integration at the point of care to providers ...
(Date:7/17/2019)... BETHLEHEM, Pa. (PRWEB) , ... July 17, 2019 , ... ... (SLUHN) plastic surgeon Juan Carlos Martinez, MD, to relieve pressure on the nerves under ... Just after the Wescosville, PA woman turned 30 last year, her debilitating headaches began ...
(Date:7/17/2019)... ... 17, 2019 , ... Athena Software , a leading ... worldwide, has been awarded a California Multiple Award Schedules (CMAS) agreement by the ... and local government agencies in California by designating pre-approved suppliers from whom they ...
Breaking Medicine News(10 mins):